Cover Image
市場調查報告書

自行注射器的全球市場:產業分析、市場規模、佔有率、成長率、趨勢、未來預測 (2014∼2020年)

Auto-Injectors Market (Product Types: Prefilled and Fillable Auto-injectors; Therapeutic Applications; Manufacturing Design) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

出版商 Transparency Market Research 商品編碼 328552
出版日期 內容資訊 英文 89 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
自行注射器的全球市場:產業分析、市場規模、佔有率、成長率、趨勢、未來預測 (2014∼2020年) Auto-Injectors Market (Product Types: Prefilled and Fillable Auto-injectors; Therapeutic Applications; Manufacturing Design) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
出版日期: 2015年03月05日 內容資訊: 英文 89 Pages
簡介

本報告提供全球自行注射器市場相關資料詳細分析、市場規模、趨勢、各治療用途的各種自行注射器的競爭等彙整資料,連同主要企業公司簡介,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 全球自行注射器市場概要

  • 簡介
  • 市場動態
  • 法律規範:全球自行注射器市場
  • 活動的影響分析:全球自行注射器市場
  • 價值鏈分析:全球自行注射器市場
  • 波特的五力分析
  • 市場魅力分析:全球自行注射器市場,各地區
  • 競爭分析

第4章 全球自行注射器市場:各產品類型

  • 簡介
  • 預填充式 (拋棄式) 自行注射器
  • 填充式 (可重複使用) 自行注射器

第5章 全球自行注射器市場:各製造設計

  • 簡介
  • 標準型自行注射器
  • 定做自行注射器

第6章 全球自行注射器市場:各治療用途

  • 簡介
  • 過敏性反應
  • 多發性硬化症
  • 類風濕性關節炎
  • 其他

第7章 全球自行注射器市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他 (RoW)

第8章 建議

  • 印度、中國等新興經濟國的投資
  • 為了提高客戶認識的行銷宣傳活動投資
  • 創新自行注射器的開發

第9章 企業簡介

  • Antares Pharma, Inc.
  • Becton, Dickinson & Company
  • Biogen Idec
  • Mylan, Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Sanofi
  • Scandinavian Health Ltd (SHL) Group
  • Unilife Corporation
  • Ypsomed Holding AG

圖表一覽

目錄

Title: Auto-Injectors Market (Product Types: Prefilled and Fillable Auto-injectors; Therapeutic Applications: Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis and Others; Manufacturing Design: Standardized and Customized Auto-injectors) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.

Auto-injectors are used for the administration of a single dose of a particular (typically life-saving) drug. They are designed for easy use and intended for self administration or administration by any untrained personnel.

This report provides an in-depth analysis of the global auto-injectors market. The stakeholders for this report include companies engaged in research and development, manufacturing, distribution, and commercialization of auto-injectors, and new entrants planning to invest in the auto-injectors market. The executive summary section of this report provides a snapshot of the auto-injectors market, which summarizes the market size, trends, and competition for different types of auto-injectors for various therapeutic applications on the global front.

The market overview section elucidates market dynamics such as drivers, restraints, and opportunities that currently have strong influence over the auto-injectors market and could impact the future scenario of the market as well. Market attractiveness analysis has been included in the market overview section in order to explicate the degree of competition among major geographies.

Porter's five forces analysis is also incorporated in this section to explore the overall competition in the auto-injectors market, considering five different parameters that have an effect on the sustainability of companies in the market. The regulatory framework section highlights the standards and recommendations, set by various government organizations worldwide, which have strong impact on the auto-injectors market. Competition between major market players is analyzed along with their market share analysis in the competitive landscape section of the report. Value chain analysis has been provided to recognize the value-creating activities from a number of processes that take place in transforming inputs to valuable outputs. Event mapping is done for a brief understanding of the technological advancements, new product launches, and strategic decisions taken by players in the global auto-injectors market. All these factors assist the market players in taking strategic decisions, which help them in escalating their market share and strengthening their positions in the global auto-injectors market.

The global auto-injectors market has been segmented on the basis of product, therapeutic applications, and manufacturing design. Based on product type, the global auto-injectors market is classified into two major segments, namely prefilled auto-injectors and fillable auto-injectors. Based on therapeutic applications, the auto-injectors market is differentiated into four segments: anaphylaxis, multiple sclerosis, rheumatoid arthritis, and others. Depending upon the manufacturing design, the global auto-injectors market is categorized into two segments: standardized auto-injectors and customized auto-injectors. Market revenue in terms of USD million for the period between 2012 and 2020 along with the compound annual growth rate (CAGR %) from 2014 to 2020 are provided for all segments, considering 2013 as the base year.

Geographically, the global auto-injectors market has been segmented into four regional markets: North America, Europe, Asia Pacific, and Rest of the World (RoW). This section of the report provides market estimations in terms of revenue (USD million) of auto-injectors across four regions from 2012 to 2020. CAGR % for the period from 2014 to 2020 is also analyzed for these four geographies, considering 2013 as the base year.

This report also includes recommendations that would help new market entrants in establishing presence and existing market players in expanding their global reach and market share in the auto-injectors market. The report concludes by profiling major players in the auto-injectors market. Company overview, financial overview, product portfolio, business strategy, and recent developments are provided for major market players in the company profile section. Major market players profiled in the report include Antares Pharma, Inc., Becton, Dickinson and Company, Biogen Idec, Inc., Mylan, Inc., Novartis International AG, Pfizer, Inc., Sanofi, Scandinavian Health Limited (SHL) Group, Unilife Corporation, and Ypsomed Holdings AG.

The global auto-injectors market has been segmented into the following categories:

Global Auto-Injectors Market, by Product Type

  • Prefilled (Disposable) Auto-injectors
  • Fillable (Reusable) Auto-injectors

Global Auto- Injectors Market, by Therapeutic Application

  • Anaphylaxis
  • Multiple Sclerosis
  • Rheumatoid Arthritis
  • Others

Global Auto-Injectors Market, by Product Type

  • Standardized Auto-injectors
  • Customized Auto-injectors

Global Auto-Injectors Market, by Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Table of Contents

Chapter 1 - Introduction

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

Chapter 2 - Executive Summary

  • 2.1. Market Snapshot: Global Auto-injectors Market
  • 2.2. Comparative Analysis: Global Auto-injectors Market, by Geography, 2013 & 2020 (Value %)

Chapter 3 - Global Auto-injectors Market Overview

  • 3.1. Introduction
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers
      • 3.2.1.1. Rising Prevalence of Anaphylaxis in Developed Countries is Increasing the Demand for Epinephrine Auto-injectors
      • 3.2.1.2. Favorable Reimbursement Policies are Encouraging Patients to Opt for Auto-injectors
      • 3.2.1.3. Efforts by Government Bodies and Market Players to Increase Awareness about the Use and Efficacy of Auto-injectors
    • 3.2.2. Market Restraints
      • 3.2.2.1. High Product Prices Restrict Patients in Emerging Economies from Purchasing Auto-injectors
    • 3.2.3. Market Opportunities
      • 3.2.3.1. High Prevalence of Food Allergies and Rheumatoid Arthritis in Emerging Economies would Drive the Demand for Auto-injectors in Asia Pacific and RoW markets
  • 3.3. Regulatory Framework: Global Auto-injectors Market
  • 3.4. Event Impact Analysis: Global Auto-injectors Market
  • 3.5. Value Chain Analysis: Global Auto-injectors Market
  • 3.6. Porter's Five Forces Analysis: Global Auto-injectors Market
    • 3.6.1. Bargaining Power of Suppliers
    • 3.6.2. Bargaining Power of Buyers
    • 3.6.3. Threat of Substitutes
    • 3.6.4. Threat of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. Market Attractiveness Analysis: Global Auto-injectors Market, by Geography
  • 3.8. Competitive Landscape
    • 3.8.1. Market Share Analysis: Global Standardized Auto-injectors Market, by Key Players, 2013 (Value %)

Chapter 4 - Global Auto-injectors Market, by Product Type

  • 4.1. Introduction
  • 4.2. Prefilled (Disposable) Auto-injectors
    • 4.2.1. Global Prefilled Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • 4.3. Fillable (Reusable) Auto-injectors
    • 4.3.1. Global Fillable Auto-injectors Market Revenue, 2012 - 2020 (USD Million)

Chapter 5 - Global Auto-injectors Market, by Manufacturing Design

  • 5.1. Introduction
  • 5.2. Standardized Auto-injectors
    • 5.2.1. Global Standardized Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • 5.3. Customized Auto-injectors
    • 5.3.1. Global Customized Auto-injectors Market Revenue, 2012 - 2020 (USD Million)

Chapter 6 - Global Auto-injectors Market, by Therapeutic Application

  • 6.1. Introduction
  • 6.2. Anaphylaxis
    • 6.2.1. Global Anaphylaxis Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • 6.3. Multiple Sclerosis
    • 6.3.1. Global Multiple Sclerosis Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • 6.4. Rheumatoid Arthritis
    • 6.4.1. Global Rheumatoid Arthritis Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Others Auto-injectors Market Revenue, 2012 - 2020 (USD Million)

Chapter 7 - Global Auto-injectors Market, by Geography

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. North America Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • 7.5. Rest of the World (RoW)
    • 7.5.1. Rest of the World Auto-injectors Market Revenue, 2012 - 2020 (USD Million)

Chapter 8 - Recommendations

  • 8.1. Invest in Emerging Economies such as India and China
  • 8.2. Investing in Marketing Campaigns to Elevate Customer Awareness
  • 8.3. Developing Innovative Auto-injectors

Chapter 9 - Company Profiles

  • 9.1. Antares Pharma, Inc.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Overview
    • 9.1.3. Product Portfolio
    • 9.1.4. Business Strategies
    • 9.1.5. Recent Developments
  • 9.2. Becton, Dickinson & Company
    • 9.2.1. Company Overview
    • 9.2.2. Financial Overview
    • 9.2.3. Product Portfolio
    • 9.2.4. Business Strategies
    • 9.2.5. Recent Developments
  • 9.3. Biogen Idec
    • 9.3.1. Company Overview
    • 9.3.2. Financial Overview
    • 9.3.3. Product Portfolio
    • 9.3.4. Business Strategies
    • 9.3.5. Recent Developments
  • 9.4. Mylan, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Financial Overview
    • 9.4.3. Product Portfolio
    • 9.4.4. Business Strategies
    • 9.4.5. Recent Developments
  • 9.5. Novartis International AG
    • 9.5.1. Company Overview
    • 9.5.2. Financial Overview
    • 9.5.3. Product Portfolio
    • 9.5.4. Business Strategies
    • 9.5.5. Recent Developments
  • 9.6. Pfizer, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Financial Overview
    • 9.6.3. Product Portfolio
    • 9.6.4. Business Strategies
    • 9.6.5. Recent Developments
  • 9.7. Sanofi
    • 9.7.1. Company Overview
    • 9.7.2. Financial Overview
    • 9.7.3. Product Portfolio
    • 9.7.4. Business Strategies
    • 9.7.5. Recent Developments
  • 9.8. Scandinavian Health Ltd (SHL) Group
    • 9.8.1. Company Overview
    • 9.8.2. Financial Overview
    • 9.8.3. Product Portfolio
    • 9.8.4. Business Strategies
    • 9.8.5. Recent Developments
  • 9.9. Unilife Corporation
    • 9.9.1. Company Overview
    • 9.9.2. Financial Overview
    • 9.9.3. Product Portfolio
    • 9.9.4. Business Strategies
    • 9.9.5. Recent Developments
  • 9.10. Ypsomed Holding AG
    • 9.10.1. Company Overview
    • 9.10.2. Financial Overview
    • 9.10.3. Product Portfolio
    • 9.10.4. Business Strategies
    • 9.10.5. Recent Developments

List of Figures

  • FIG. 1: Auto-injectors Market Segmentation
  • FIG. 2: Global Auto-injectors Market, by Product Type and by Manufacturing Design, 2013 (USD Million)
  • FIG. 3: Global Auto-injectors Market, by Therapeutic Applications, 2013 (USD Million)
  • FIG. 4: Comparative Analysis: Global Auto-injectors Market, by Geography, 2013 & 2020 (Value %)
  • FIG. 5: Value Chain Analysis: Global Auto-injectors Market
  • FIG. 6: Porter's Five Forces Analysis: Global Auto-injectors Market
  • FIG. 7: Market Attractiveness Analysis: Global Auto-injectors Market, by Geography
  • FIG. 8: Market Share Analysis: Global Standardized Auto-injectors Market, by Key Players, 2013 (Value %)
  • FIG. 9: Global Prefilled Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 10: Global Fillable Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 11: Global Standardized Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 12: Global Customized Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 13: Global Anaphylaxis Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 14: Global Multiple Sclerosis Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 15: Global Rheumatoid Arthritis Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 16: Global Others Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 17: North America Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 18: Europe Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 19: Asia Pacific Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 20: Rest of the World Auto-injectors Market Revenue, 2012 - 2020 (USD Million)
  • FIG. 21: Antares Pharma, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 22: Becton, Dickinson & Company: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 23: Biogen Idec: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 24: Mylan, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 25: Novartis International AG: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 26: Pfizer, Inc.: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 27: Sanofi: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 28: Unilife Corporation: Annual Revenue, 2011 - 2013 (USD Million)
  • FIG. 29: Ypsomed Holding AG: Annual Revenue, 2011 - 2013 (USD Million)

List of Tables

  • TABLE 1: Market Snapshot: Global Auto-injectors Market
  • TABLE 2: Global Auto-injectors Market Revenue, by Product Type, 2012 - 2020 (USD Million)
  • TABLE 3: Global Auto-injectors Market Revenue, by Manufacturing Design, 2012 - 2020 (USD Million)
  • TABLE 4: Major Auto-injectors Brand with Therapeutic Applications
  • TABLE 5: Global Auto-Injectors Market Revenue, by Therapeutic Application, 2012 - 2020 (USD Million)
  • TABLE 6: Global Auto-injectors Market Revenue, by Geography, 2012 - 2020 (USD Million)
Back to Top